$UNH (+0,32 %) reaffirms its 2025 EPS outlook despite the Amedisys deal being dilutive.
Preliminary CMS star ratings show ~78% of members in 4⭐️+ plans — in line with history and expectations. Strong quality metrics = steady revenue stream.
$UNH (+0,32 %) reaffirms its 2025 EPS outlook despite the Amedisys deal being dilutive.
Preliminary CMS star ratings show ~78% of members in 4⭐️+ plans — in line with history and expectations. Strong quality metrics = steady revenue stream.